Vitamin markets show weak demand and slow price movement
The global feed vitamins market has entered a period of relative stability following earlier price declines. While overall sentiment remains weak, most markets show minimal changes compared to previous weeks, and Q2 is largely contracted.
In partnership with Feed Additive Prices
Vitamin E 50%
Not a lot of changes compared to previous reports. After a period of price decline, there is a more stable situation now in most markets, although the underlying sentiment remains somewhat weak. Suppliers are firm on the price or do not even offer anything. Q2 is contracted.
Vitamin A 1000
Prices continue to decline step by step and market participants are starting to wonder where this will end. BASF is not even back on the market yet, that should be still the case in April/May 2025. Demand seems slightly weaker and there is still surplus material available at traders. No signs of nearby change in the market trend. Vitamin A1000 in the USA is exempt from the latest tariffs. Q2 is well contracted, but Q3 is still mostly open.
Vitamin D3 500
A slight price decline is seen either due to exchange rate developments or by sellers who want to move some material. Overall, the supply seems to be tight but at the same time, the demand is slightly behind. As a result, the price is still high, however, there is a small step-by-step decline seen in most regions. Apparently, there are several import codes in the USA for vitamin D3, one is exempt and the other one is not. So, it is not clear yet what the impact will be on the price development in the USA. Q2 is contracted.
Vitamin B2 80%
The vitamin B2 market remains steady, showing no significant changes compared to previous weeks, with consistent pricing and a favourable outlook on supply availability. Also in the USA the prices have stayed relatively stable so far, as it seems that vitamin B2 is exempt from the latest announced import tariffs. Looking ahead, no major fluctuations are expected in the near future. Most contracts for the second quarter are already secured.
D-Calpan
The base price FOB China is very stable at a low level. In the USA no price change is seen as d-calpan is exempt from the latest tariffs. In Europe, the price came down slightly this week due to the EUR-USD exchange rate. Q2 is well contracted.
Vitamin B3
After a period of price decline the last few weeks, the market seems more stable now, at a relatively low price level. One of the manufacturers claimed force majeure some time ago, but that has not impacted the market really. Most of Q2 and a portion of Q3 is contracted and buyers are at the sideline for any additional volumes. Vitamin B3 is exempt from the latest US tariffs.
Biotin
No changes are seen in the biotin market. Only the USA, the biotin pure price increased slightly as a result of the first round of tariff increases. Biotin is exempt from the latest round of tariffs. Prices in other regions are stable, although it went down slightly in Europe due to exchange rate impact. Q2 and a portion of Q3 is contracted already.
Vitamin C 35% mono
The market overall is weak for vitamin C and there is some oversupply. Together with a strong euro against the USD, prices in Europe have been coming down lately. In the USA prices are basically stable as the first rounds of tariffs offset the overall price decline. Vitamin C is exempt from the latest tariffs. Prices in China are stable to weak. Q2 is mostly contracted.
